Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis-Reference-Cited by-同舟云学术

Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis

Published:2020-12 Issue:4 Volume:13 Page:232-237
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Hashmi Hamza,Bhandari Shruti,Kumar Rohit,Tripathi Prashant,Rhodes Jill Blancett,Figg Lindsay,Baize Timothy,Krem Maxwell M.,Hegazi Mohamed,Emmons Robert

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference13 articles.

1. Pathogenesis and management of graft-versus-host disease;Choi;Immunol Allergy Clin North Am,2010

2. Pharmacokinetics, pharmacodynamics and pharmacogenomics of immunosuppressants in allogeneic haematopoietic cell transplantation: Part I;McCune;Clin Pharmacokinet,2016

3. Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation;Przepiorka;Biol Blood Marrow Transplant,1999

4. Astellas Pharma Tech Co., Ltd. PROGRAF. July 2018. Available from: https://www.astellas.us/docs/prograf.pdf (accessed May 1, 2020).

5. Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation;Skeens;Bone Marrow Transplant,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of intermittent intravenous tacrolimus to continuous tacrolimus in adult allogeneic stem cell transplant recipients;Journal of Oncology Pharmacy Practice;2024-05-05

2. Butyryl chitosan: Synthesis, characterization and evaluation of the sustained release performance as tacrolimus carrier;Chemical Engineering Journal;2022-10